Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Adderall XR sales suspended in Canada

Feb. 14, 2005

Phase IIb/III DIAS2 study begins for desmoteplase in acute ischemic stroke

Feb. 14, 2005

ReceptoPharm plans phase IIb/III study of RPI-78M in adrenomyeloneuropathy

Feb. 14, 2005

Ondansetron improves auditory gating in schizophrenic patients

Feb. 14, 2005

Putative antidepressant LY-367265 inhibits glutamate release in rat cortex

Feb. 14, 2005

Neuroprotective effects of thiazolidinediones in a preclinical model of stroke

Feb. 14, 2005

Abbott presents new dopamine D3 modulators for schizophrenia

Feb. 11, 2005

Role for the NO-NSAID HCT-1026 in the control of microglia activation

Feb. 11, 2005

First data on the efficacy of androgen antagonists in bulimia nervosa

Feb. 11, 2005

SSR-149415 exerts antidepressant-like effects through vasopressin V1b receptors in lateral septum

Feb. 11, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...